Healthequity Stock Market Sentiment

HQY
 Stock
  

USD 57.67  3.72  6.06%   

Healthequity investor sentiment overview provides quick insight into current market opportunities from investing in Healthequity. The current market sentiment together Healthequity's historical and current headlines can help investors to time the market. Many technical investors use Healthequity stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Healthequity Hype Analysis, Healthequity Correlation and Healthequity Performance.
  
Refresh
Healthequity stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Healthequity daily returns and investor perception about the current pice of Healthequity as well as its diversification or hedging effects on your existing portfolios.

Healthequity Latest Sentiment Indicators

200 Day MA
59.06
Short Percent
0.0567
Short Ratio
5.89
Shares Short Prior Month
3.8 M
50 Day MA
62.76
52 Week Low
36.81
Shares Short
4.2 M

Healthequity Current Investor Sentiment

Investor biases related to Healthequity's public news can be used to forecast risks associated with investment in Healthequity. The trend in average sentiment can be used to explain how an investor holding Healthequity can time the market purely based on public headlines and social activities around Healthequity. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Healthequity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Healthequity's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Healthequity's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Healthequity.

Healthequity Maximum Pain Price across 2022-07-15 Option Contracts

Healthequity's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Healthequity close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Healthequity's options.
over six months ago at www.marketbeat.com         
190.20 Million in Sales Expected for HealthEquity, Inc. This Quarter - MarketBeat
Marketbeat News
over six months ago at seekingalpha.com         
HealthEquity, Inc. S-3ASR Sep. 9, 2021 441 PM - Seeking Alpha
seekingalpha News
over six months ago at Macroaxis         
Will Healthequity (NASDAQ:HQY) price continue sliding?
Macroaxis News
over six months ago at www.macroaxis.com         
Healthequity exotic insider transaction detected
Macroaxis News
over six months ago at www.benzinga.com         
A Look Into HealthEquitys Debt - Benzinga
benzinga news
over six months ago at www.nasdaq.com         
Analysts Estimate HealthEquity to Report a Decline in Earnings What to Look Out for - Nasdaq
nasdaq News
over six months ago at www.equities.com         
Healthequity falls 0.06 percent to Close at 64.17 on August 31 - Equities.com
Equities News
over six months ago at www.equities.com         
Healthequity falls 2.40 percent for August 30 - Equities.com
Equities News
over six months ago at www.equities.com         
Healthequity falls 0.54 percent to Close at 64.10 on August 26 - Equities.com
Equities News
over six months ago at www.equities.com         
Healthequity falls 0.23 percent to Close at 64.45 on August 25 - Equities.com
Equities News
over six months ago at www.macroaxis.com         
Healthequity exotic insider transaction detected
Macroaxis News
over six months ago at www.gurufocus.com         
Strategic Advisors LLC Buys Moderna Inc, ARK Fintech Innovation ETF, Industrial Select Sector SPDR, ...
Gurufocus Stories at Macroaxis
over six months ago at www.equities.com         
Healthequity falls 0.30 percent on Moderate Volume August 19 - Equities.com
Equities News
over six months ago at finance.yahoo.com         
Allscripts hosts Developer Challenge Advancing Health Equity Using Social Determinants of Health - Y...
Yahoo News
over six months ago at www.equities.com         
Healthequity falls 4.82 percent to Close at 61.85 on August 17 - Equities.com
Equities News
There is far too much social signal, news, headlines, and media speculation about Healthequity that is available to investors today. That information is available publicly through Healthequity media outlets and privately through word of mouth or via Healthequity internal channels. However, regardless of the origin, that massive amount of Healthequity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Healthequity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Healthequity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Healthequity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Healthequity alpha.

Healthequity Performance against DOW

 Price Growth (%)  
      Timeline 
1
EPS Reported06/17/2020
2
Filing06/26/2020
3
Financial Statements07/08/2020
4
Financial Statements07/09/2020
5
Financial Statements07/13/2020
6
Other07/15/2020
7
EPS Estimate07/31/2020
8
EPS Reported09/08/2020
9
EPS Estimate10/28/2020
10
Financial Statements12/04/2020
11
EPS Reported12/07/2020
12
Financial Statements01/11/2021
13
Unclassified Event01/27/2021
14
EPS Estimate01/28/2021
15
Financial Statements02/08/2021
16
Unclassified Event02/09/2021
17
Unclassified Event02/10/2021
18
Unclassified Event02/11/2021
19
Financial Statements02/17/2021
20
Financial Statements02/19/2021
21
Other03/02/2021
22
Financial Statements03/08/2021
23
EPS Reported03/15/2021
24
Financial Statements04/01/2021
25
Financial Statements04/08/2021
26
Financial Statements04/14/2021
27
Healthequity exotic insider transaction detected04/21/2021
28
Financial Statements04/27/2021
29
EPS Estimate04/30/2021
30
Financial Statements05/06/2021
31
EPS Reported06/07/2021
32
Financial Statements06/08/2021
33
Healthequity exotic insider transaction detected06/22/2021
34
Financial Statements06/24/2021
35
Exercise or conversion by Frank Corvino of 4762 shares of He...06/25/2021
36
Healthequity exotic insider transaction detected06/30/2021
37
Payment of 1201 shares by Hostetter Adam J of Healthequity s...07/01/2021
38
Healthequity exotic insider transaction detected07/19/2021
39
Healthequity exotic insider transaction detected07/22/2021
40
Healthequity exotic insider transaction detected07/27/2021
41
EPS Estimate07/28/2021
42
Financial Statements08/13/2021
43
Healthequity exotic insider transaction detected08/16/2021
44
Healthequity exotic insider transaction detected08/24/2021
45
Healthequity exotic insider transaction detected09/03/2021
46
EPS Reported09/08/2021
47
Healthequity exotic insider transaction detected09/21/2021
48
Financial Statements09/29/2021
49
Financial Statements09/30/2021
50
Healthequity exotic insider transaction detected10/04/2021
51
Financial Statements10/05/2021
52
Sale by Debra McCowan of 8132 shares of Healthequity10/06/2021
53
Financial Statements10/12/2021
54
EPS Estimate10/28/2021
55
HealthEquity Completes Further Acquisition - Marketscreener....11/01/2021
56
Healthequity exotic insider transaction detected11/03/2021
57
EPS Reported12/06/2021
58
Healthequity exotic insider transaction detected12/10/2021
59
Exercise or conversion by Angelique Hill of 10100 shares of ...12/13/2021
60
Healthequity exotic insider transaction detected12/15/2021
61
Healthequity exotic insider transaction detected12/16/2021
62
Healthequity exotic insider transaction detected12/21/2021
63
Financial Statements01/10/2022
64
EPS Estimate01/31/2022
65
Acquisition by Parker Stuart B of 1212 shares of Healthequit...02/03/2022
66
Unclassified Event02/07/2022
67
A look at Blue Shield of Californias new maternal health equ...02/10/2022
68
Unclassified Event02/11/2022
69
Financial Statements02/22/2022
70
EPS Reported03/22/2022
71
HealthEquity price target raised to 66 from 62 at Deutsche B...03/24/2022
72
Acquisition by Rosner Elimelech of 59480 shares of Healthequ...04/01/2022
73
Weve always had the answers Put underserved patients in the ...04/04/2022
74
Payment of 1025 shares by Murdock Tyson D of Healthequity su...04/05/2022
75
Acquisition by Stephen Neeleman of 9535 shares of Healthequi...04/14/2022
76
Gamida Cell Announces Results of New Health Economic and Out...04/25/2022
77
EPS Estimate04/27/2022
78
Acquisition by Parker Stuart B of 1212 shares of Healthequit...04/29/2022
79
Financial Statements05/02/2022
80
Healthequity exotic insider transaction detected05/04/2022
81
New legislation calls on CMMI to create model based on healt...05/13/2022
82
Financial Statements05/16/2022
83
Pear Announces Health Equity Data Showing Similar Engagement...05/23/2022
84
EPS Reported06/06/2022
85
UnitedHealth Groups Foundation Commits 100 Million To Health...06/08/2022
86
Big Fed Rate Hike Or Very Big Hike Market Awaits - Investors...06/14/2022
87
Financial Statements06/23/2022
88
Acquisition by Parker Stuart B of 2996 shares of Healthequit...06/27/2022
Please check Healthequity Hype Analysis, Healthequity Correlation and Healthequity Performance. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
4.9 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.